NDC 51655-913 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC51655-913

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Northwind Health Company, LLC
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
January 22, 2021
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (3)

Package NDCDescriptionSince
51655-913-2020 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-20)Jun 3, 2022
51655-913-5310 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-53)Jan 22, 2021
51655-913-5415 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-54)Mar 15, 2023

Other Ondansetron products